HomeCompareBAX vs BAC

BAX vs BAC: Dividend Comparison 2026

BAX yields 2.28% · BAC yields 2.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BAC wins by $88.3K in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
BAC
BAC
● Live price
2.33%
Share price
$47.23
Annual div
$1.10
5Y div CAGR
47.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$109.0K
Annual income
$39,185.81
Full BAC calculator →

Portfolio growth — BAX vs BAC

📍 BAC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXBAC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + BAC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
BAC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
BAC
Annual income on $10K today (after 15% tax)
$197.97/yr
After 10yr DRIP, annual income (after tax)
$33,307.94/yr
At 15% tax rate, BAC beats the other by $33,299.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + BAC for your $10,000?

BAX: 50%BAC: 50%
100% BAC50/50100% BAX
Portfolio after 10yr
$64.8K
Annual income
$19,598.04/yr
Blended yield
30.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BAC right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
BAC
Analyst Ratings
35
Buy
18
Hold
1
Sell
Consensus: Buy
Price Target
$60.33
+27.7% upside vs current
Range: $50.00 — $71.00
Altman Z
-0.3
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
BAC buys
0
No recent congressional trades found for BAX or BAC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXBAC
Forward yield2.28%2.33%
Annual dividend / share$0.36$1.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%47.1%
Portfolio after 10y$20.6K$109.0K
Annual income after 10y$10.26$39,185.81
Total dividends collected$602.00$81.7K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusHoldBuy
Analyst price target$19.75$60.33

Year-by-year: BAX vs BAC ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrBAC PortfolioBAC Income/yrGap
1← crossover$10,866$166.33$11,043$342.60$177.00BAC
2$11,750$123.31$12,336$520.10$586.00BAC
3$12,664$90.97$13,998$798.75$1.3KBAC
4$13,617$66.89$16,224$1,246.06$2.6KBAC
5$14,619$49.07$19,345$1,985.44$4.7KBAC
6$15,679$35.94$23,954$3,254.61$8.3KBAC
7$16,802$26.30$31,171$5,540.30$14.4KBAC
8$17,998$19.23$43,264$9,911.45$25.3KBAC
9$19,272$14.05$65,205$18,912.41$45.9KBAC
10$20,631$10.26$108,955$39,185.81$88.3KBAC

BAX vs BAC: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

BACFinancials

Bank of America Corporation, through its subsidiaries, provides banking and financial products and services for individual consumers, small and middle-market businesses, institutional investors, large corporations, and governments worldwide. Its Consumer Banking segment offers traditional and money market savings accounts, certificates of deposit and IRAs, noninterest-and interest-bearing checking accounts, and investment accounts and products; and credit and debit cards, residential mortgages, and home equity loans, as well as direct and indirect loans, such as automotive, recreational vehicle, and consumer personal loans. The company's Global Wealth & Investment Management segment offers investment management, brokerage, banking, and trust and retirement products and services; and wealth management solutions, as well as customized solutions, including specialty asset management services. Its Global Banking segment provides lending products and services, including commercial loans, leases, commitment facilities, trade finance, and commercial real estate and asset-based lending; treasury solutions, such as treasury management, foreign exchange, and short-term investing options and merchant services; working capital management solutions; and debt and equity underwriting and distribution, and merger-related and other advisory services. The company's Global Markets segment offers market-making, financing, securities clearing, settlement, and custody services, as well as risk management products using interest rate, equity, credit, currency and commodity derivatives, foreign exchange, fixed-income, and mortgage-related products. As of December 31, 2021, it served approximately 67 million consumer and small business clients with approximately 4,200 retail financial centers; approximately 16,000 ATMs; and digital banking platforms with approximately 41 million active users. The company was founded in 1784 and is based in Charlotte, North Carolina.

Full BAC Calculator →
📬

Get this BAX vs BAC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.